People who had a prior heart attack who were given 40 infusions of EDTA chelation therapy compared to those given a placebo were 18% less likely to die from any cause, have a heart attack, have a stroke, have coronary revascularization, or hospitalization for angina over the next 5 years.
A subset of people who were Type 2 diabetics had a 41% lower risk of these events happening.
EDTA chelation helps to remove heavy metals such as lead and cadmium.
“[A] body of epidemiological data showing that accumulation of biologically active metals, such as lead and cadmium, is an important risk factor for cardiovascular disease,” the authors of the paper note.
© Copyright 2003-2021 - Larry Hobbs - All Rights Reserved.